Neurovascular and neuroimmune aspects in the pathophysiology of rosacea.
about
The role of brimonidine tartrate gel in the treatment of rosaceaRosacea: Molecular Mechanisms and Management of a Chronic Cutaneous Inflammatory ConditionSkin barrier in rosaceaTopical Ivermectin 10 mg/g and Oral Doxycycline 40 mg Modified-Release: Current Evidence on the Complementary Use of Anti-Inflammatory Rosacea TreatmentsMultidisciplinary Consideration of Potential Pathophysiologic Mechanisms of Paradoxical Erythema with Topical Brimonidine TherapyImproving Treatment of Erythematotelangiectatic Rosacea with Laser and/or Topical Therapy Through Enhanced Discrimination of its Clinical Features[Dermatological diseases and their importance for psychiatry].Recent advances in the understanding and management of rosacea.Mast cells are key mediators of cathelicidin-initiated skin inflammation in rosaceaRosacea: new and emerging treatments.Management of cutaneous rosacea: emphasis on new medical therapies.A study on the epidemiology of rosacea in the U.K.Altered manifestations of skin disease at sites affected by neurological deficit.Comparative efficacy of intense pulsed light for different erythema associated with rosacea.Augmented supraorbital skin sympathetic nerve activity responses to symptom trigger events in rosacea patients.Distribution and expression of non-neuronal transient receptor potential (TRPV) ion channels in rosaceaAdvances in understanding and managing rosacea: part 2: the central role, evaluation, and medical management of diffuse and persistent facial erythema of rosacea.Advances in understanding and managing rosacea: part 1: connecting the dots between pathophysiological mechanisms and common clinical features of rosacea with emphasis on vascular changes and facial erythemaProspective Comparison of Dual Wavelength Long-Pulsed 755-nm Alexandrite/1,064-nm Neodymium:Yttrium-Aluminum-Garnet Laser versus 585-nm Pulsed Dye Laser Treatment for Rosacea.Dermasence refining gel modulates pathogenetic factors of rosacea in vitro.Corneal and conjunctival sensitivity in rosacea patients.Clinical, cellular, and molecular aspects in the pathophysiology of rosacea.Once-daily topical brimonidine tartrate gel 0·5% is a novel treatment for moderate to severe facial erythema of rosacea: results of two multicentre, randomized and vehicle-controlled studies.Kallikrein 5-mediated inflammation in rosacea: clinically relevant correlations with acute and chronic manifestations in rosacea and how individual treatments may provide therapeutic benefitSkin disorders in Parkinson's disease: potential biomarkers and risk factors.Proteases and proteomics: cutting to the core of human skin pathologies.Facial dystonias and rosacea: is there an association?Endoplasmic reticulum stress: key promoter of rosacea pathogenesis.Brimonidine tartrate for the treatment of facial flushing and erythema in rosacea.Integrative concepts of rosacea pathophysiology, clinical presentation and new therapeutics.Friends or Foes? Host defense (antimicrobial) peptides and proteins in human skin diseases.Rosacea and gastrointestinal disorders: a population-based cohort study.Topical Treatment of Rosacea with Ivermectin Inhibits Gene Expression of Cathelicidin Innate Immune Mediators, LL-37 and KLK5, in Reconstructed and Ex Vivo Skin Models.Topical a-Agonist Therapy for Persistent Facial Erythema of Rosacea and the Addition of Oxmetazoline to the Treatment Armamentarium: Where Are We Now?The association between psychiatric diseases, psychotropic drugs and the risk of incident rosacea.Antihypertensive drugs and the risk of incident rosacea.An observational cross-sectional survey of rosacea: clinical associations and progression between subtypes.[Current insights into the pathophysiology of rosacea].Rosacea, the face of innate immunity.Quality of life among patients with rosacea: an investigation of patients in China using two structured questionnaires.
P2860
Q26777249-B667A3BD-5F85-496F-83BE-51AC52AD7052Q28067747-51F1B834-5942-4DA6-AAF1-38DB4D7DCF90Q28069342-7C735E50-870E-4CAC-B8AC-C826F8BE8B03Q28072685-DA8A2265-136D-45F3-B65E-92D5F9D9433DQ28077384-D1C7886C-C9B8-49CA-A872-06EA1DA2592DQ28077479-BAB41A6E-A044-4F00-8247-5ECE508BF7EEQ30251786-906A5906-8EBD-4A8D-A30E-4DFE1B972B1AQ33942083-E45D096C-4243-4E2C-A85B-F250FF990990Q34353391-289E7C17-84DC-4433-AE11-8862946355B5Q34434971-13FFEE7C-21C8-4704-82BE-09F101712524Q34436744-54C7BCAB-0AB5-43C2-8C1E-43430C4EC1C4Q34638049-47D952A3-4F94-4110-B43D-2D982E49954DQ35079603-68E31ACC-89BF-47E7-A8E7-186522195F5BQ35230579-F798A4A7-CB4D-4CE1-AB10-32F860B887CAQ35680501-D48AACED-D624-4D57-B853-D741C795D768Q35834762-5ADA70B2-EC8F-4083-922E-B640371487B1Q35862102-0E93B713-FFB5-4AB0-98B3-03254B1E2E3FQ35862114-CF55B578-0761-4CD0-9E74-FB135FB86BC6Q36164626-DDC4DE97-87CC-4CE7-9D11-6235DBDA6ED4Q36325038-38F78BC0-1470-4AFA-BAEC-FF854ABD54BEQ36595369-862D82B3-692A-4511-BF94-F794102F7701Q36991412-1C9AD716-4511-44A8-A92F-6EC3880AAF51Q37013298-F0D39422-E0D8-4FD1-83B9-70C5AE5A94E6Q37595472-B4CB34A6-8D78-47B8-B582-240F5EBEAC7BQ37702287-09C8DBB4-A5F9-4DC1-AE7C-524772966B5BQ38200069-DA90C3CC-A245-4E7E-97B8-68EEFDDB479AQ38212027-9AA1978D-50E0-4CC8-9672-0A3DB259DB00Q38232251-85D1F6B0-FD0F-4068-89DD-58808E35DB1FQ38236823-759DEB2E-3DE0-47B6-9D70-EC384191426AQ38885566-7028956E-1B70-4D6E-BDD1-85A66F34F603Q39133115-1B006050-2E57-4363-A893-58C6C2143C10Q39512887-05A2F88B-81FB-4D8A-9F59-81A38FC8C262Q42230578-93941467-F320-4AC5-891C-32C3F963C2B6Q43379739-18AFF0A3-80B7-424E-92F6-55EB3C95D9A8Q43793565-29F4D312-AA27-4C9F-BFA0-177236244548Q44804086-5212122E-60F2-47E4-AC37-DFFCBCB71027Q45153232-D127FCCE-6366-45F7-BD4C-48D69B99FA9CQ46276685-599B916B-85F3-4B16-96E1-50D3B5450743Q46464886-33AF769F-81A8-4129-9355-7EE2B0FCEE8EQ47641618-1EBDDEE9-4EEB-4691-A600-294C749E6BD1
P2860
Neurovascular and neuroimmune aspects in the pathophysiology of rosacea.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Neurovascular and neuroimmune aspects in the pathophysiology of rosacea.
@en
type
label
Neurovascular and neuroimmune aspects in the pathophysiology of rosacea.
@en
prefLabel
Neurovascular and neuroimmune aspects in the pathophysiology of rosacea.
@en
P2093
P2860
P356
P1476
Neurovascular and neuroimmune aspects in the pathophysiology of rosacea.
@en
P2093
Christian Mess
Dieter Metze
Ferda Cevikbas
Isabelle Carlavan
Jerome Aubert
Johannes J Voegel
Jörg Buddenkotte
Martin Steinhoff
Mathias Sulk
Michel Rivier
P2860
P2888
P356
10.1038/JIDSYMP.2011.6
P577
2011-12-01T00:00:00Z
P5875
P6179
1045753458